Metropolis Healthcare Share Price

Metropolis Healt

CMP as on 16-May-22 15:45

₹ 1,946.60
-69.65 -3.45%

Open

₹ 1,995.05

Turnover (lac)

₹ 6,512

Prev. Close

₹ 2,016.25

Day's Vol (shares)

₹ 3,34,531

Day's Range (₹)

₹ 1,884.55
₹ 1,995.50

CMP as on16-May-22 15:29

₹ 1,940.00
-76.55 -3.8%

Open

₹ 2,016.55

Turnover (lac)

₹ 255

Prev. Close

₹ 2,016.55

Day's Vol (shares)

₹ 12,819

Day's Range

₹ 1,885.45
₹ 2,016.55

CMP as on 16-May-22 0:00

₹ 1,875.00
-96.15 -4.88%

Open

₹ 1,929.95

Open Interest(Contracts)

₹ 4,24,400

VWAP

₹ 1,878.82

Day's Vol (shares)

₹ 4,48,800

Day's Range (Ex.Dt. 26 May 2022)

₹ 1,821.05
₹ 1,940.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Feb-2022 - -
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve 1. Consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2021. 2. Consider the proposal for declaration of an Interim Dividend for the Financial Year 2021-22 if any. i. Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021 and took note of the Limited Review Report issued by the Statutory Auditors on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021. ii. Approved and declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two only) per Equity Share for the Financial Year 2021-22. This is to inform you that the Board of Directors of the Company at their meeting held today have inter-alia approved and declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two only) per Equity Share for the Financial Year 2021-22. i. Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021 and took note of the Limited Review Report issued by the Statutory Auditors on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021. The copy of the Unaudited Standalone & Consolidated Financial Results of the Company as approved by the Board of Directors together with the Limited Review Report thereon for the quarter and nine months ended December 31, 2021 is enclosed as Annexure - 1 ii. Approved and declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two only) per Equity Share for the Financial Year 2021-22. (As Per BSE Announcement Dated 11.02.2022) We refer to our letter dated February 11, 2022 submitting Unaudited Consolidated Financial Results for the quarter and nine months ended December 31, 2021, Auditors Limited Review Report and the requisite declaration on unmodified opinion (Reference no. MHL/Sec&Legal/2021-22/71) There was a typographical error in the Limited Review Report for the quarter and nine months ended December 31, 2021 that inadvertently referred to Regulation 52(4) read with Regulation 63(2) in addition to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please find enclosed the correct Limited Review Report for the quarter and nine months ended December 31, 2021.We further state that there is no change in the revenue, profit before tax, profit and earnings per share (EPS) numbers of the Group reported in the Unaudited Consolidated Financial Results submitted to you on February 11, 2022. (As Per BSE Announcement Dated on 12.02.2022)
Board Meeting - 09-Feb-2022 - -
With reference to the captioned subject and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that pursuant to the approval of the Board of Directors through Circular Resolution passed on January 14, 2022, the Company has transferred on February 09, 2022, 100 (Hundred) Equity Shares of Dr. Ganesans Hitech Diagnostic Centre Private Limited (Hitech) (Wholly owned subsidiary of the Company) to Amins Pathology Laboratory Private Limited (Amins), a wholly-owned subsidiary of the Company, at a total consideration of Rs. 1,97,333/- (Rupees One Lakh Ninety-Seven Thousand Three Hundred and Thirty-Three Only). Accordingly, post transfer of said Equity Shares of Hitech, the direct holding of the Company in Hitech stand at 99.99% and the balance stake will be held through Amins, a wholly owned subsidiary of the Company.
Board Meeting - 03-Nov-2021 - -
Quarterly Results This is to inform you that the Board of Directors of the Company at their meeting held today have inter-alia approved the Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter and half-year ended September 30, 2021 and took note of the Limited Review Report issued by the Statutory Auditors of the Company on the Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter and half-year ended September 30, 2021. (As Per BSE Announcement Dated on 10/11/2021)
Board Meeting - 15-Oct-2021 - -
Outcome of the Board meeting held on October 15, 2021
Board Meeting - 31-Jul-2021 - -
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 2021; Proposal for raising funds either by way of private placement or preferential issue or public issue or through any other permissible mode and/or combination thereof, including by way of Qualified Institutions Placement, in accordance with applicable laws; and other matters Outcome of the Board meeting held on August 06, 2021 (As Per BSE Announcement Dated on 06.08.2021)
Board Meeting - 08-Jul-2021 - -
Dear Sir / Madam, With reference to the captioned subject, we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company has on July 8, 2021, approved the allotment of 25,416 (Twenty Five Thousand Four Hundred and Sixteen) Equity Shares of Rs. 2/- (Rupees Two Only) each at an Exercise price of Rs.2 (Rupees Two Only) per Equity Share aggregating to Rs. 50,832/- (Rupees Fifty Thousand Eight Hundred and Thirty Two Only) to the eligible employees of the Company who have exercised their stock units pursuant to the Metropolis - Restrictive Stock Unit Plan, 2020 (MHL-RSU Plan 2020).
Board Meeting - 21-May-2021 - -
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the year ended March 31, 2021. Outcome of Board Meeting dated May 27, 2021 The Board approved the appointment of Mr. Hemant Sachdev as an Additional Non-Executive Non-Independent Director of the Company, who shall hold office till the date of the forthcoming Annual General Meeting and shall continue to hold office thereafter, subject to the approval of the members of the Company at the forthcoming Annual General Meeting. Board has accepted and took on record the resignation of Ms. Poonam Tanwani from the post of Company Secretary and Compliance Officer of the Company with effect from close of business hours of May 31, 2021 and approved the appointment of Mr. Danish Allana, Associate Company Secretary (having membership no. A61517) as an Interim Compliance Officer of the Company with effect from June 1, 2021. (As per BSE Announcement Dated on 27/05/2021) Dear Sir/Madam, This is to inform you that the Board of Directors of the Company on May 27, 2021 approved the Audited Standalone and Consolidated Financial Statements of the Company for the quarter and year ended March 31, 2021. In this regard and pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein enclose the copy of the Newspaper Advertisement dated May 27, 2021 published in the following newspapers: 1. Free Press Journal (English) 2. Navshakti (Marathi) (As per BSE Announcement Dated on 28/05/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity